HDL Size Test

Your standard cholesterol panel reports one number for HDL (high-density lipoprotein), the so-called good cholesterol. That single value says nothing about the actual particles carrying it. Two people with identical HDL cholesterol can have very different particle populations, and those differences may matter for heart disease, diabetes, and kidney health.

HDL size measures the average diameter of those particles. It opens a window into HDL biology that routine labs cannot show. The science here is still evolving, so a single reading should be read as one piece of a bigger picture rather than a verdict.

What HDL Size Actually Measures

HDL particles are tiny packages of proteins and fats your body uses to move cholesterol out of tissues and back to the liver. They are not all the same. They range from very small particles roughly 7 to 9 nanometers across (a nanometer is a billionth of a meter) up to large particles around 10 to 13 nanometers. Larger particles tend to be richer in cholesterol. Smaller particles tend to be richer in protein and are often more active in pulling cholesterol out of cells.

This test reports the weighted-average diameter of your HDL population, typically measured by a lab method called NMR (nuclear magnetic resonance, a technology that uses magnetic fields to size lipid particles). A higher number means your HDL population skews larger. A lower number means it skews smaller. The number itself is just an average, so two people with the same HDL size can still have very different mixes of small and large particles underneath.

Why Size Matters Beyond HDL Cholesterol

HDL cholesterol mostly tracks the cholesterol mass inside the larger HDL particles. It does not tell you how many particles you have or what sizes they come in. Studies that measure HDL particle number and size find that these properties often carry information about heart and metabolic risk that HDL cholesterol alone misses, especially in people who already have diabetes, kidney disease, or established heart disease.

The relationship is not simple. In some settings, larger average HDL size looks protective. In others, it looks harmful. The same is true of small HDL. That is why HDL size is best read alongside HDL particle number, your full lipid panel, and your overall risk picture, not as a stand-alone number.

Heart Disease Risk

In a study of about 2,955 apparently healthy men and women followed for incident coronary heart disease, smaller HDL particle size was linked to higher risk, but the link was largely explained once standard risk factors like blood pressure, diabetes, and LDL cholesterol were taken into account. In broad, low-risk populations, HDL size adds modest predictive information once the basics are accounted for.

In a low-cardiovascular-risk Brazilian cohort of 284 adults, those with HDL size above about 8.22 nanometers had less subclinical thickening of the carotid artery wall than those with smaller HDL, independent of other risk factors. Across multiple cohorts, mean HDL size in healthy adults clusters around 9.0 to 9.5 nanometers.

In a large multiethnic analysis of 15,371 adults, two specific size-based HDL subspecies modestly improved prediction of future heart attacks and other vascular events on top of standard risk factors. So while HDL size is not a stand-alone heart attack predictor in healthy adults, the underlying particle distribution carries real signal.

Heart Failure Risk

A multicohort analysis of 16,925 adults without prior heart failure found that having more HDL particles was associated with lower future heart failure risk, while having larger average HDL size was associated with higher risk. HDL cholesterol itself showed no clear link to heart failure once these particle features were considered. In a separate study of 422 chronic heart failure patients, larger HDL size and altered cholesterol content predicted cardiovascular death independently of standard risk factors.

In other words, in the heart failure context, bigger HDL particles do not look like a good sign. This is one of the clearest examples of why HDL size cannot be read like LDL cholesterol, where lower is reliably better.

Diabetes and Kidney Disease

In 1,991 adults with type 2 diabetes followed in the Hong Kong Diabetes Biobank, having more small HDL particles was associated with lower cardiovascular disease and lower all-cause mortality. In 550 adults with type 1 diabetes, very small (extra-small) HDL particles were the strongest HDL-related predictor of new coronary artery disease events, and they outperformed HDL cholesterol. In a study of 4,828 adults from the PREVEND cohort, larger HDL size and certain HDL subspecies were linked to a lower risk of developing type 2 diabetes.

In chronic kidney disease, the picture flips again. In 325 adults with kidney disease, higher HDL particle size was associated with new cardiovascular events. In a separate group of 183 patients with kidney disease, low concentrations of medium-sized HDL particles predicted future cardiovascular events, suggesting medium HDL may be especially protective in this group.

Reconciling the Paradox: Bigger Is Not Always Better

The findings above can look contradictory. Larger HDL size predicts lower carotid thickening in low-risk adults, lower diabetes risk in healthy populations, and worse outcomes in heart failure and chronic kidney disease. The framework that makes both consistent is this: HDL size is not a good-or-bad number. It is a phenotype indicator. The same average diameter can come from very different underlying particle distributions, with very different functional properties depending on the metabolic environment.

In someone metabolically healthy, larger HDL often reflects intact reverse cholesterol transport, the process by which HDL ferries cholesterol back to the liver for disposal. In someone with chronic disease, larger HDL can reflect particles loaded with the wrong cargo, less efficient at their job. That is why HDL size is most useful when read alongside HDL particle number, your other lipids, and your specific health context, not as a verdict on its own.

Reference Ranges

There are no universally accepted clinical cutpoints for HDL size. The values below come from research cohorts using NMR or similar particle-sizing methods. Different labs and different methods can produce different absolute numbers for the same blood sample, so use these as orientation, not a target. Compare your results within the same lab over time for the most meaningful trend.

These orientation values draw from multiethnic cohorts including studies in apparently healthy adults, type 2 diabetes biobanks, and heart failure analyses using NMR-based particle sizing. They are illustrative, not diagnostic thresholds.

Tracking Your Trend

A single HDL size reading is unreliable for clinical decisions. Methods vary across labs, the result depends on your recent metabolic state, and the same number can mean different things depending on your other lipids. Tracking the direction over time is far more informative than any one value.

Get a baseline now, retest in 3 to 6 months if you are making lifestyle changes or starting medications that affect lipids, and at minimum recheck annually. Pair every reading with HDL particle number, triglycerides, ApoB (apolipoprotein B, a marker of harmful cholesterol particle count), and the rest of your standard lipid panel. The pattern across these markers tells you more than any individual number.

When Results Can Be Misleading

Several factors can shift HDL size readings without reflecting a meaningful change in your underlying biology. Knowing them helps you avoid overreacting to a single result.

• Lab method: NMR results may not match results from other particle-sizing methods like ion mobility or gradient gel electrophoresis. Stick to one lab for serial comparisons.
• Recent fasting or major dietary shifts: Even a 36-hour fast can reduce small HDL particles and raise average HDL size temporarily. Test in your usual fed-or-fasted state for consistent comparisons.
• Acute illness or recent surgery: Inflammation reshapes HDL composition for days to weeks. Wait at least 4 to 6 weeks after a significant illness before drawing conclusions.
• Pregnancy and major weight changes: Both shift HDL composition and size in ways that are not necessarily long-term.

What an Abnormal Result Should Trigger

If your HDL size sits at the extreme ends of the population distribution, do not act on that number alone. Look at the pattern. A small HDL size combined with high triglycerides, low HDL cholesterol, and a high TG/HDL ratio points toward insulin resistance, and the right next step is a deeper metabolic workup with fasting insulin, HbA1c, and ApoB.

A large HDL size combined with very high HDL cholesterol (above about 90 mg/dL) is worth paying attention to, especially if you have hypertension or known heart disease, because that combination has been associated with higher mortality in some populations. A lipidologist or preventive cardiologist can help interpret unusual HDL patterns in the context of your full risk picture, including ApoB, lipoprotein(a), coronary calcium, and family history. The goal is never to chase HDL size up or down. The goal is to use the pattern to refine your risk estimate and inform what gets treated.